|
SNAPC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.221800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.633900E-02 |
| Normal-vs-Stage2 |
7.871700E-02 |
| Normal-vs-Stage3 |
5.297800E-03 |
| Normal-vs-Stage4 |
9.849700E-02 |
| Stage1-vs-Stage2 |
9.022000E-01 |
| Stage1-vs-Stage3 |
7.174000E-02 |
| Stage1-vs-Stage4 |
9.549600E-01 |
| Stage2-vs-Stage3 |
2.854200E-01 |
| Stage2-vs-Stage4 |
9.689400E-01 |
| Stage3-vs-Stage4 |
3.116400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.960000E-02 |
| Normal-vs-AfricanAmerican |
1.173850E-02 |
| Normal-vs-Asian |
2.129800E-01 |
| Caucasian-vs-AfricanAmerican |
2.947400E-01 |
| Caucasian-vs-Asian |
4.784200E-01 |
| AfricanAmerican-vs-Asian |
6.597000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.379900E-03 |
| Normal-vs-Female |
1.207420E-01 |
| Male-vs-Female |
8.132200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.015400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.304100E-02 |
| Normal-vs-Age(61-80Yrs) |
9.441700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.623800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.854400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.952000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.795400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.796200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.581400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.825200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.138400E-01 |
| Normal-vs-Grade 2 |
1.973420E-01 |
| Normal-vs-Grade 3 |
4.716500E-03 |
| Normal-vs-Grade 4 |
2.855200E-03 |
| Grade 1-vs-Grade 2 |
7.707400E-01 |
| Grade 1-vs-Grade 3 |
1.645590E-01 |
| Grade 1-vs-Grade 4 |
1.003150E-01 |
| Grade 2-vs-Grade 3 |
2.216500E-03 |
| Grade 2-vs-Grade 4 |
3.560900E-03 |
| Grade 3-vs-Grade 4 |
4.659200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.790970E-01 |
| Normal-vs-ccB subtype |
3.776500E-03 |
| ccA subtype-vs-ccB subtype |
2.338100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.831690E-02 |
| Normal-vs-N1 |
4.936300E-02 |
| N0-vs-N1 |
1.804400E-01 |
|
|
